These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16102651)

  • 1. Neonatal candidiasis.
    Smith PB; Steinbach WJ; Benjamin DK
    Infect Dis Clin North Am; 2005 Sep; 19(3):603-15. PubMed ID: 16102651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal therapy for neonatal candidiasis.
    Zaoutis T; Walsh TJ
    Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
    Healy CM; Baker CJ; Zaccaria E; Campbell JR
    J Pediatr; 2005 Aug; 147(2):166-71. PubMed ID: 16126043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices.
    Burwell LA; Kaufman D; Blakely J; Stoll BJ; Fridkin SK
    Pediatrics; 2006 Oct; 118(4):e1019-26. PubMed ID: 16982807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of Candida infections in neonates.
    Chapman RL
    Semin Perinatol; 2007 Feb; 31(1):39-46. PubMed ID: 17317426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micafungin for the prophylaxis and treatment of Candida infections.
    Fritz JM; Brielmaier BD; Dubberke ER
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
    Kaufman DA
    Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
    Vendettuoli V; Vento G; Tirone C; Posteraro B; Romagnoli C
    Pediatrics; 2009 Feb; 123(2):e368-9. PubMed ID: 19171602
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.
    Benjamin DK; Stoll BJ; Fanaroff AA; McDonald SA; Oh W; Higgins RD; Duara S; Poole K; Laptook A; Goldberg R;
    Pediatrics; 2006 Jan; 117(1):84-92. PubMed ID: 16396864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of invasive fungal infection in very low birthweight infants.
    Brecht M; Clerihew L; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of candida prophylaxis in neonates (author's transl)].
    Azubuike JC; Niesen M
    Z Geburtshilfe Perinatol; 1973 Dec; 177(6):446-8. PubMed ID: 4788134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.